Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Socazolimab plus platinum-based chemotherapy with or without bevacizumab versus placebo plus platinum-based chemotherapy with or without bevacizumab for first-line cervical cancer
CTR20242900Phase 3Active
- Sponsor
- Zhaoke Ophthalmology
- Start
- Nov 2024
- Modality
- Immune Checkpoint Inhibitors → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of socazolimab in Cervical Cancer (CC), sponsored by Zhaoke Ophthalmology. Started Nov 2024; status: active.
02
Drugs
socazolimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on CTR20242900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242900.